8-K filed November 30, 2021, 6:59 PM ET ticker BFNH CIK 0001310488

leadership confidence high sentiment neutral materiality 0.60

BioForce Nanosciences appoints Co-CEOs and President, CEO Merle Ferguson resigns

BIOFORCE NANOSCIENCES HOLDINGS, INC.

CEO & President Merle Ferguson resigned Nov 30, 2021; remains Chairman, no dispute with company.
Steve Gagnon and John LaViolette appointed Co-CEOs effective Nov 30, 2021.
Sasha Shapiro appointed President effective Nov 30, 2021.
New officers are from Element Global (OTC Pink) and have entertainment industry backgrounds.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Merle Ferguson

Chief Executive Officer and President

BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.

Effective: 2021-11-30
Successor: Steve Gagnon, John LaViolette, Sasha Shapiro
Filed: November 30, 2021, 6:59 PM ET

the Board of Directors accepted the resignation of Mr. Merle Ferguson as Chief Executive Officer and President, effective November 30, 2021.

Appointed

John LaViolette

Co-Chief Executive Officer

BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.

Effective: 2021-11-30
Filed: November 30, 2021, 6:59 PM ET

appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.

Appointed

Sasha Shapiro

President

BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.

Effective: 2021-11-30
Filed: November 30, 2021, 6:59 PM ET

appointed Sasha Shapiro as President, effective November 30, 2021.

Appointed

Steve Gagnon

Co-Chief Executive Officer

BFNH · BIOFORCE NANOSCIENCES HOLDINGS, INC.

Effective: 2021-11-30
Filed: November 30, 2021, 6:59 PM ET

appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Merle Ferguson resigned as Chief Executive Officer and President at BIOFORCE NANOSCIENCES HOLDINGS, INC..

Action: resigned
Role: Chief Executive Officer and President

Exact text from the filing

the Board of Directors accepted the resignation of Mr. Merle Ferguson as Chief Executive Officer and President, effective November 30, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John LaViolette was appointed as Co-Chief Executive Officer at BIOFORCE NANOSCIENCES HOLDINGS, INC..

Action: appointed
Role: Co-Chief Executive Officer

Exact text from the filing

appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Sasha Shapiro was appointed as President at BIOFORCE NANOSCIENCES HOLDINGS, INC..

Action: appointed
Role: President

Exact text from the filing

appointed Sasha Shapiro as President, effective November 30, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Steve Gagnon was appointed as Co-Chief Executive Officer at BIOFORCE NANOSCIENCES HOLDINGS, INC..

Action: appointed
Role: Co-Chief Executive Officer

Exact text from the filing

appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.

View on SEC.gov

BIOFORCE NANOSCIENCES HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001091818-21-000150

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.